Citeline Solutions

1. Managing Execution Of A Phase III Clinical Trial 3/9/2026

   Clinical trials must accommodate operational challenges and changes in the market, which includes a sponsor's ability to forecast site activation, monitor resources, and track competitive activity.

2. Accelerate Enrollment And Reduce Site Burden 2/18/2026

   Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.

3. How AI Is Setting A New Standard In Clinical Development 11/13/2025

   Learn how to adopt artificial intelligence in practical, measurable ways, from protocol feasibility and cohort modeling to clinical trial disclosure and transparency.

4. A New Blueprint For Transforming Feasibility And Recruitment 10/20/2025

   Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.

5. No Statistically Significant Progress — Yet 10/20/2025

   Dr. Jennifer E. Miller of the Yale School of Medicine says her Good Pharma Scorecard found no statistically significant diversity improvements in oncology trials over the past decade, despite decades of policy efforts and major investments.

6. Community Trust Can't Be Outsourced 10/20/2025

   Dr. Brescher underscores that authentic community trust can’t come from corporate messaging alone. It grows when people from within the community lead research conversations and build relationships grounded in shared experience.

7. What Bright Spots In Trial Diversity Are Doing Differently 10/20/2025

   According to Dr. Miller, the “bright spot” sponsors making real progress are those abandoning one-size-fits-all vendors, investing in patient navigators, and leveraging broader site networks to improve representation across studies.

8. The Real Story Behind SOGI Data In Clinical Trials 10/20/2025

   In this clip, Dr. Jessica Brecher of Tectonic Therapeutic reveals why many trial sites refuse to activate sexual-orientation and gender-identity (SOGI) questions — from investigator discomfort to patient fears — and why collecting these data is scientifically essential.

9. Health Equity Isn't A Buzzword — It's A Business Imperative 10/20/2025

   Dr. Camille (Pope) Campbell of Biogen explains that health equity isn’t just moral — it’s strategic. She details how Biogen integrates equity into community outreach, operations, and commercialization to improve both outcomes and business impact.

10. TrialScope Disclose: Plan With Purpose, Disclose With Confidence 10/2/2025

    TrialScope Disclose is the industry’s most trusted and comprehensive clinical trial disclosure solution. Simplify, centralize, and gain complete control of your entire global disclosure process from trial planning to results submission, ensuring full transparency and regulatory disclosure compliance at every stage.